Indications |
Oral Peripheral vascular disease Adult: 75 mg bid or tid. Elderly: Oral Motion sickness Adult: 30 mg taken 2 hr before travel and 15 mg every 8 hr during the journey if necessary. Child: 5-12 yr: 1/ Oral Cerebrovascular disorders Adult: 75 mg 1-3 times daily. Oral Vertigo and vestibular disorders Adult: 30 mg tid. Child: 5-12 yr: 1/ |
Contraindications |
Proven hypersensitivity to the drug. Parkinson's disease. Childn and neonates. |
Warnings / Precautions |
Hypotension; pregnancy; lactation; elderly. May impair ability to drive or operate machineries. |
Adverse Reactions |
Extrapyramidal symptoms sometimes associated with severe depression. Drowsiness, headache, GI upsets, unsteadiness, headache; rarely skin and hypersensitivity reactions, dry mouth, blurred vision, urinary difficulty or retention, constipation and increased gastric reflux, fatigue. Hypolipidaemic effect. |
Drug Interactions |
CNS depressant effect enhanced with alcohol. Action potentiated by domperidone. See Below for More cinnarizine Drug Interactions |
Mechanism of Actions |
Cinnarizine has calcium-channel blocking activity selective for arterial smooth muscle. It also has some antihistamine activity. Cinnarizine acts as a labyrinthine sedative. It also improves microcirculation by reducing ischaemia-induced blood viscosity. Absorption: Absorbed from the GIT (oral); peak plasma concentrations after 2-4 hrs. Excretion: Via faeces (as unchanged drug), via urine (as metabolites); 3-6 hrs (elimination half-life). |
Administration |
Should be taken with food. |
ATC Classification |
N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations. |
Available As |
|
Cinnarizine
Post Review about Cinnarizine Click here to cancel reply.
Cinnarizine Containing Brands
Cinnarizine is used in following diseases
Drug - Drug Interactions of Cinnarizine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.